10x Genomics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period
10x Genomics, Inc. (TXG) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period of 1.86 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod · last filed 2026-08-07
- 10x Genomics, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for the quarter ending 2026-06-30 was 1.06M shares, a 25.31% increase year-over-year.
- 10x Genomics, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for the quarter ending 2026-03-31 was 807.85K shares, a 43.06% increase year-over-year.
- 10x Genomics, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for the quarter ending 2025-12-31 was 849.59K shares, a 45.92% increase year-over-year.
- 10x Genomics, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for the quarter ending 2025-09-30 was 860.08K shares, a 61.40% increase year-over-year.
- 10x Genomics, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2025 was 3.12M shares, a 48.96% increase from fiscal 2024.
- 10x Genomics, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2024 was 2.09M shares, a 10.10% increase from fiscal 2023.
- 10x Genomics, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2023 was 1.90M shares, a 116.33% increase from fiscal 2022.
- 10x Genomics, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2022 was 878.57K shares, a 129.76% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.06M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | 1.86M shares 10-Q · filed 2026-08-07 | 2.71M shares derived: sum of 3 quarters · filed 2026-08-07 | 3.57M shares derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | 807.85K shares 10-Q · filed 2026-05-08 | 1.66M shares derived: sum of 2 quarters · filed 2026-05-08 | 2.52M shares derived: sum of 3 quarters · filed 2026-05-08 | 3.36M shares derived: sum of 4 quarters · filed 2026-05-08 |
| 2025-12-31 | 849.59K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | 1.71M shares derived: sum of 2 quarters · filed 2026-02-13 | 2.55M shares derived: sum of 3 quarters · filed 2026-02-13 | 3.12M shares 10-K · filed 2026-02-13 |
| 2025-09-30 | 860.08K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | 1.70M shares derived: sum of 2 quarters · filed 2025-11-07 | 2.27M shares 10-Q · filed 2025-11-07 | 2.85M shares derived: sum of 4 quarters · filed 2025-11-07 |
| 2025-06-30 | 842.71K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | 1.41M shares 10-Q · filed 2025-08-08 | 1.99M shares derived: sum of 3 quarters · filed 2025-08-08 | 2.52M shares derived: sum of 4 quarters · filed 2025-08-08 |
| 2025-03-31 | 564.70K shares 10-Q · filed 2025-05-09 | 1.15M shares derived: sum of 2 quarters · filed 2025-05-09 | 1.68M shares derived: sum of 3 quarters · filed 2025-05-09 | 2.21M shares derived: sum of 4 quarters · filed 2025-05-09 |
| 2024-12-31 | 582.25K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | 1.12M shares derived: sum of 2 quarters · filed 2025-02-13 | 1.65M shares derived: sum of 3 quarters · filed 2025-02-13 | 2.09M shares 10-K · filed 2025-02-13 |
| 2024-09-30 | 532.89K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | 1.07M shares derived: sum of 2 quarters · filed 2024-10-29 | 1.51M shares 10-Q · filed 2024-10-29 | 1.98M shares derived: sum of 4 quarters · filed 2024-10-29 |
| 2024-06-30 | 532.28K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | 977.39K shares 10-Q · filed 2024-08-08 | 1.44M shares derived: sum of 3 quarters · filed 2024-08-08 | 1.96M shares derived: sum of 4 quarters · filed 2024-08-08 |
| 2024-03-31 | 445.11K shares 10-Q · filed 2024-04-30 | 911.90K shares derived: sum of 2 quarters · filed 2024-04-30 | 1.42M shares derived: sum of 3 quarters · filed 2024-04-30 | 1.95M shares derived: sum of 4 quarters · filed 2024-04-30 |
| 2023-12-31 | 466.79K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | 978.00K shares derived: sum of 2 quarters · filed 2024-02-15 | 1.50M shares derived: sum of 3 quarters · filed 2024-02-15 | 1.90M shares 10-K · filed 2024-02-15 |
| 2023-09-30 | 511.21K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | 1.04M shares derived: sum of 2 quarters · filed 2023-11-03 | 1.43M shares 10-Q · filed 2023-11-03 | 1.82M shares derived: sum of 4 quarters · filed 2023-11-03 |
| 2023-06-30 | 525.40K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | 922.62K shares 10-Q · filed 2023-08-04 | 1.31M shares derived: sum of 3 quarters · filed 2023-08-04 | 1.50M shares derived: sum of 4 quarters · filed 2023-08-04 |
| 2023-03-31 | 397.22K shares 10-Q · filed 2023-05-04 | 780.24K shares derived: sum of 2 quarters · filed 2023-05-04 | 974.30K shares derived: sum of 3 quarters · filed 2023-05-04 | 1.17M shares derived: sum of 4 quarters · filed 2023-05-04 |
| 2022-12-31 | 383.02K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | 577.07K shares derived: sum of 2 quarters · filed 2023-02-16 | 769.37K shares derived: sum of 3 quarters · filed 2023-02-16 | 878.57K shares 10-K · filed 2023-02-16 |
| 2022-09-30 | 194.06K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | 386.36K shares derived: sum of 2 quarters · filed 2022-11-03 | 495.55K shares 10-Q · filed 2022-11-03 | 611.33K shares derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-06-30 | 192.30K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | 301.50K shares 10-Q · filed 2022-08-09 | 417.27K shares derived: sum of 3 quarters · filed 2022-08-09 | 515.24K shares derived: sum of 4 quarters · filed 2022-08-09 |
| 2022-03-31 | 109.20K shares 10-Q · filed 2022-05-05 | 224.97K shares derived: sum of 2 quarters · filed 2022-05-05 | 322.94K shares derived: sum of 3 quarters · filed 2022-05-05 | 440.49K shares derived: sum of 4 quarters · filed 2022-05-05 |
| 2021-12-31 | 115.78K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | 213.75K shares derived: sum of 2 quarters · filed 2022-02-18 | 331.29K shares derived: sum of 3 quarters · filed 2022-02-18 | 382.38K shares 10-K · filed 2022-02-18 |
| 2021-09-30 | 97.97K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | 215.51K shares derived: sum of 2 quarters · filed 2021-11-05 | 266.60K shares 10-Q · filed 2021-11-05 | 308.46K shares derived: sum of 4 quarters · filed 2021-11-05 |
| 2021-06-30 | 117.55K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | 168.63K shares 10-Q · filed 2021-08-06 | 210.49K shares derived: sum of 3 quarters · filed 2021-08-06 | 251.37K shares derived: sum of 4 quarters · filed 2021-08-06 |
| 2021-03-31 | 51.09K shares 10-Q · filed 2021-05-07 | 92.94K shares derived: sum of 2 quarters · filed 2021-05-07 | 133.82K shares derived: sum of 3 quarters · filed 2021-05-07 | |
| 2020-12-31 | 41.86K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | 82.73K shares derived: sum of 2 quarters · filed 2021-02-26 | 123.73K shares 10-K · filed 2021-02-26 | |
| 2020-09-30 | 40.88K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | 81.88K shares 10-Q · filed 2020-11-12 | ||
| 2020-06-30 | 41.00K shares 10-Q · filed 2020-08-12 |